Welcome to the Parlor Games Research Lab!

DHEA is a complex hormone, as we've written about at length in this blog and it can have a number of amazing positive effects throughout the entire body. When we were developing ReBounce DHEA cream, we wanted to be sure that we had a solid statistical base about how women can utilize the cream. Unlike topical estriol and progesterone, of which there is a lot of existing research (you can check it out here), there are fewer studies that focus on topical DHEA for post-menopausal women and their symptoms. We wanted to learn more about how DHEA affects women post-menopause!

About the Study

- The study was 60 days.
- 44 participants, with 39 who did the full 60 days.
- 5mg of ReBounce DHEA per day.
- All participants were 55+, with the average age being 63.

Focus One: The Symptoms That Existed BEFORE ReBounce DHEA

We wanted to know what issues were bothering women during their menopause that they felt they needed a resolution for, but had not been able to find using other product, supplements, or lifestyle adjustments. When we polled the 45 women in the test group, we found that the major issue many women reported (70%) was unwanted weight gain. A significant number (60%) also reported vaginal dryness, which may have been due to the fact that we recruited existing customers, and our flagship product is for vaginal dryness. Fatigue was at 58% and lack of energy and brain fog were at 55%, all of which are often intangible symptoms that can be a real struggle to resolve.

As you can see from the above diagram, a large number of women in the group were suffering from an overall loss of energy and related symptoms.

DHEA is a steroid hormone produced by the ovaries and the adrenal glands, and it plays a vital role in the body's hormone balance. DHEA is a precursor hormone that can be converted into other hormones, such as estrogen and testosterone, which play essential roles in the body. Otherwise known as a prohormone, DHEA is the most abundant naturally occurring base for hormones in the body. Humans make more and more DHEA from birth to about age 25. People make the most DHEA during their prime reproductive years – optimum health, energy, mental sharpness – between the ages of 18 to 25. This is when humans are naturally most fit to have children, think clearly, and have the physical strength to best care for their offspring (read: to help them deal with the traumatic experience that is raising a toddler…). At around 30, DHEA levels begin to decline for the remainder of life at a rate of about 2% per year. By age 70 to 80 years, DHEA levels can be as low as 20% to 10% compared to younger people. Because DHEA is important for many functions in the body, its decline correlates with the steady decline in many functions in the body – those often associated with the aging process and the increase in disease states.

As such, these women were excellent candidates for the product test, and to see whether ReBounce DHEA would help with these symptoms.

Focus Two: Changes From ReBounce DHEA

After 60 on ReBounce, we surveyed the women to see which of the listed symptoms had been helped by supplementation. Over 60% of women found mood swings had lessened (i.e., shown improvement). Additionally, fatigue, lack of energy, anxiety, brain fog, and weight all showed an improvement of over 40%; in fact, of the 39 women who finished the product test, 38 of the product test participants said they would continue to use ReBounce DHEA after the ReBounce test ended.

The only area surveyed in which the participants found negative outcomes was an increase in facial hair. This is not uncommon; we discuss this more on our blog on hair loss, but DHEA converts to testosterone, which converts to DHT, which plays a significant role in both hair growth and loss.

The diagram below shows the overall percentage improvement of all participants across the different symptoms.

Conclusions

In conclusion, 38 of the 39 participants who finished the product test decided to continue with ReBounce DHEA, and there was a remarkable improvement across 21 of the 22 domains that affected post-menopausal women. Furthermore, 50% of the symptoms showed some level of improvement, and an additional 25-50% showed significant improvement. Only 1 symptom worsened, as discussed.